상품상세정보

의학서적전문 "성보의학서적"의 신간의학도서입니다.

The clearest, most concise coverage of one of the most complex topics in medicine—updated with the latest advances in the field
Clinical Neurology, Eleventh Edition, provides a comprehensive overview of basic and clinical neurology in a concise, digestible format. It links clinical neuroscience to current approaches for accurately diagnosing and effectively treating neurologic disorders. Covering all the advances in molecular biology and genetics, this popular guide emphasizes history-taking and neurologic examination as the cornerstones of diagnosis. All information is thoroughly up-to-date and presented as a practice-oriented approach to neurology based on the patient's presenting symptoms or signs.
Features:
• 350+ tables and figures
• Chapter outlines providing overview of each topic
• Treatment protocols reflecting the most recent advances in the field
• Step-by-step review of the neurologic examination

-도서목차-

Chapter 1. NeurologicHistory & Examination
Neurologic examination ofsphincter function
Chapter 2. InvestigativeStudies
Neuromuscular imaging studies
Update on ultrasonography forneuromuscular diagnosis
Chapter 3. Coma
Introduction
Role of prefrontal cortex in consciousness
Causes of coma
Spontaneous intracranialhypotension as a cause of coma
Persistent vegetative state
New imaging insights intopersistent vegetative & minimally conscious states
Treatment of traumatic vegetative &minimally conscious states with amantadine
Chapter 4. ConfusionalStates
Drugs
Serotonin syndrome
Electrolyte disorders
Antidepressant-inducedhyponatremia
Endocrine & metabolic disorders
Mechanisms of impairedhypoglycemia sensing in treated diabetes
Nutritional disorders
Furosemide-induced thiaminedeficiency
Organ system failure
ICU delirium
Postoperative cognitivedysfunction
Meningitis, encephalitis & sepsis
Mechanism of N. meningitidis vascular spread
Dysregulated host inflammatoryresponse in tuberculous meningitis
CSF findings in HIV-infectedpatients with tuberculous meningitis
Tick-borne encephalitis & (re-emergent)yellow fever
Nipah virus encephalitis
Updated diagnostic testing forviral encephalitis
New recommendation on empiricaltreatment of toxoplasmosis in AIDS
Fexinidazole for treatment of Africantrypanosomiasis
Mechanism of meningeal invasion inleukemia
Chapter 5. Dementia& Amnestic Disorders
Introduction
Somatic neuronal mutations in aging and neurodegeneration
Differential diagnosis
Biomarker-based diagnostic algorithms for dementia syndromes
Neurodegenerativeproteinopathies
Tau folding in Alzheimer vs. Pickdisease
Tau-disrupted nucleocytoplasmictransport in Alzheimer disease pathogenesis
Contrasting mechanisms ofaggregate toxicity in neurodegeneration
Herpes simplex virus infection andAlzheimer disease
Inflammation in Alzheimer diseasepathogenesis
Meningeal lymphatics (glymphatics)in Alzheimer disease pathogenesis
Blood pressure and risk of Alzheimerdisease
Relation between epilepsy anddementia
Exercise training in dementia
Sex differences in Alzheimerdisease
Spatial navigation deficits asearly signs of Alzheimer disease
Subjective cognitive decline in relationto Alzheimer disease
Update on biomarkers for Alzheimerdisease
Concomitant neurodegenerativeproteinopathies
Update on clinical trials oftreatments for Alzheimer disease (eg, solanezumab, verubecestat)
Clinical and pathologicalcorrelates of primary progressive aphasia variants
New consensus guidelines fordiagnosis & treatment of dementia with Lewy bodies
Skin prions in Creutzfeldt-Jakobdisease infectivity and diagnosis
Other cerebral disorders
Shunting response to gait vs. dementia in normal pressurehydrocephalus
Normal pressure hydrocephalus vs.neurodegenerative ventriculomegaly
Mild traumatic brain injury & dementia
Systemic disorders
Subclinical hyperthyroidism &dementia
Pseudodementia
Features of memory impairment in depression
Amnestic syndromes
Update on antibody-mediatedencephalitis antigens & treatment
Chapter 6. Headache& Facial Pain
Migraine
Triptans, SSRIs & serotoninsyndrome
CGRP receptor-blocking monoclonalantibodies (eg, erenumab, fremanezumab)
Prochlorperazine plusdiphenhydramine vs. hydromorphone for IV migraine therapy
Vagus nerve stimulation as acute therapyfor migraine
Reconsideration of medicationoveruse headache
Update on sustained release drugs
Safety of migraine drugs in pregnancyand breast-feeding
Cluster headache
 CGRPreceptor-blocking monoclonal antibodies
Giant cell arteritis
Tocilizumab for treatment ofgiant-cell arteritis
Intracranial mass
Molecular classification of braintumors
Subventricular zone origin ofglioblastoma multiforme
Nivolumab plus ipilimumab formelanoma brain metastases
Chapter 7. Neuro-OphthalmicDisorders
Update on imaging of optic nervedisorders (optical coherence tomography)
Nonarteritic anterior ischemic optic neuropathy inobstructive sleep apnea
Erectile dysfunction drugs & nonarteritic anterior ischemicoptic neuropathy
Updated consensus management ofpseudotumor cerebri
Update on imaging of giant cellarteritis (ultrasound, MRI, PET)
Charles Bonnet syndrome incortical blindness
Chapter 8. Disordersof Equilibrium
New Figure: Sites of involvement in peripheral vestibular disorders
Peripheral vestibular disorders
Self-treatment of benign paroxysmal positional vertigo
Cerebellar & central vestibulardisorders
Autoimmune septin-5 cerebellarataxia
Cerebellar histiocytosis
Sensory ataxias
Nonataxic symptoms in FriedreichAtaxia
Chapter 9. MotorDisorders
Spinal cord disorders
Ibudilast for treatment of progressivemultiple sclerosis
Simvastatin for cognitivedysfunction in secondary progressivemultiple sclerosis
Clinical differentiation oftransverse myelitis etiologies
Circumferential resectioncord-compressing tumors (vs. decompressive laminectomy)
Anterior horn cell disorders
Kinesin family member 5A (KIF5A) mutationsassociated with ALS
Edaravone for treatment of ALS
Nusinersen for treatment oflater-onset spinal muscular atrophy
Disorders of peripheral nerve
Critical illness neuromyopathy(updating critical illness polyneuropathy) & management
Disorders of neuromuscular transmission
Bilevel positive airway pressure(BiPAP) for myasthenic crisis
Tensilon®replaced by Enlon® (both edrophonium) for myasthenia testing
Eculizumab for treatment ofmyasthenia gravis
Chapter 10. SensoryDisorders
New Table: Pharmacologic Treatment of Pain
Approach to diagnosis
Neuropathic itch: causes &treatment
Polyneuropathies
Guillain-Barrésyndrome associated with bone and digestive organ surgery
Autoantibodies in chronic inflammatory demyelinatingpolyradiculoneuropathy
Polyneuropathy with monoclonal gammopathy of uncertain significance
Fluoroquinolone-induced polyneuropathy
Patisiran treatment of hereditarytransthyretin-mediated amyloidosis
Chapter 11. MovementDisorders
Parkinsonism
LRRK2 activation in idiopathic Parkinson disease
Postural tremor subtypes in Parkinson disease
Light therapy treatment of Parkinsondisease
Chapter 12. Seizures& Syncope
Seizures
Update on sustained release drugs
Safety of anticonvulsant drugs inpregnancy and breast-feeding
Newly approved anticonvulsantdrugs: clobazam, eslicarbazepine, perampanel,
Cannabidiol for treatment of Lennox-Gastaut& Dravet syndromes
Hypothermia not associated with betteroutcome in status epilepticus
No increased risk of seizures withattention-deficit disorder medications
Syncope
Relative efficacy of nonpharmacologicinterventions for orthostatic hypotension
Chapter 13. Stroke
Approach to diagnosis
Updated epidemiology ofcerebrovascular disease
Focal cerebral ischemia—approach to diagnosis
Temporal trends in ischemic stroke subtypes
Five-year risk of stroke after TIAor minor ischemic stroke (2018 study)
Factors associated with emergencyroom misdiagnosis of stroke
Focal cerebral ischemia—pathophysiology
Skull bone marrow in post-strokeinflammatory response
Focal cerebral ischemia—etiology
New perspectives on cerebral smallvessel disease
Preeclampsia, posterior reversible encephalopathy syndrome, and stroke
Late-life systolic and diastolicblood pressure and risk of stroke
Intra-ictal blood pressure and poststroke cognitive impairment
Blood lipid profiles in relationto stroke subtypes
Psychological stress as a risk factor for stroke
Sepsis as a risk factor for stroke
Update on genetics, epidemiology& management of cerebrovascular fibromuscular dysplasia
Update on ischemic stroke incancer patients and its treatment
Stroke risk in occult and manifest cancers
Biopsy vs. imaging findings in primaryCNS vasculitis
Update on patent foramen ovaleclosure for cryptogenic stroke
Effects of sex and aura on strokerisk in migraine
Role of paradoxical embolism instroke in migraineurs
Presentations and treatment updatein cerebral venous and sinus thrombosis
Focal cerebral ischemia—prevention & treatment
LDL cholesterol target levels forsecondary stroke prevention
Stroke prevention in the veryelderly
Hypercoagulability workup for nonatheroscleroticischemic stroke
Aspirin for primary stroke preventionin diabetes mellitus
Diagnosis & management of theantiphospholipid syndrome in stroke prevention
Embolic stroke after leftventricular endocardial ablation
American Heart Association 2018 guidelines for management of acuteischemic stroke
Aspirin ± clopidogrel for acute ischemic strokeand TIA
Betrixaban vs. enoxaparin forstroke prophylaxis in hospitalized patients
Ezetimibe for stroke prevention inacute coronary syndrome
Rivaroxaban ±aspirin for secondary stroke prevention
Rivaroxaban vs.aspirin for secondary prevention after cryptogenic stroke
Andexanet alfa for reversing bleeding from factor Xa inhibitor treatment
Timing for initiating statin therapy after acute ischemic stroke
Warfarin vs. vitamin K antagonists for embolic stroke prevention inatrial fibrillation
Reappraisal of endarterectomy forasymptomatic carotid stenosis
Leukoaraiosis & risk of hemorrhage after thrombolysis
Tenecteplase versus alteplase thrombolysis before thrombectomy forischemic stroke
Safety of thrombolysis in patients on non–vitamin K antagonist oralanticoagulants
Time to endovascular treatment and outcome in acute ischemic stroke
Endovascular thrombectomy 6-24hours after stroke onset
MRI-guided thrombolysis for stroke withunknown time of onset
Endovascular therapy for distalintracranial occlusions
Effect of intravenous thrombolysisprior to mechanical thrombectomy on stroke outcome
Effect of interhospital transferon stroke outcome after thrombectomy
EmboTrap thrombectomy for acuteischemic stroke from large-vessel occlusion
Conscious sedation vs. localanesthesia for endovascular treatment of stroke
Cervical nerve transfer for limbparalysis after stroke
Focal cerebral ischemia—complications & rehabilitation
Mechanisms of cardiac complications after stroke
Hyperglycemia & post-strokeinfection
Microbiological etiologies of pneumonia complicating stroke
Post-stroke fatigue and itstreatment
Post-stroke anxiety subtypes
Long-term risk of post-strokeseizures
Mechanisms of motor compensationafter stroke
Robotic exosuits for strokerehabilitation
Intracerebral hemorrhage
Etiology of deep vs. superficial cerebellar hemorrhage
Update on etiology & outcome of perimesencephalic hemorrhage
Risk of intracerebral hemorrhage from warfarin vs. direct oralanticoagulants
Effects of statins on incidence of intracerebral and subarachnoidhemorrhage
Blood pressure target to prevent brain ischemia after intracerebralhemorrhage
Genetics of intracranial aneurysms
Medical vs. interventional therapy for unruptured brain AVMs: results ofrandomized trial
Spetzler–Martin grading scale & treatment of brain AVMs
Update on genetics and bleedingrisk of cranial cavernous malformations
Global cerebral ischemia
Early hyperoxia and neurologicalfunction after cardiac arrest
Epinephrine & neurological outcomeafter cardiac arrest

기타 의학도서에  관련된 문의사항은 고객센터(02-854-2738) 또는 저희 성보의학서적 홈페이지내 도서문의 게시판에 문의바랍니다.
감사합니다.
성보의학서적 "http://www.medcore.kr

상품결제정보

고액결제의 경우 안전을 위해 카드사에서 확인전화를 드릴 수도 있습니다.

확인과정에서 도난 카드의 사용이나 타인 명의의 주문등 정상적인 주문이 아니라고 판단될 경우 임의로 주문을 보류 또는 취소할 수 있습니다.  

무통장 입금은 상품 구매 대금은 PC뱅킹, 인터넷뱅킹, 텔레뱅킹 혹은 가까운 은행에서 직접 입금하시면 됩니다.  
주문시 입력한 입금자명과 실제입금자의 성명이 반드시 일치하여야 하며, 3일 이내로 입금을 하셔야 하며 입금되지 않은 주문은 자동취소 됩니다.

배송정보

• 배송 방법 : 택배
• 배송 지역 : 전국지역
• 배송 비용 : 2,500원
• 배송 기간 : 3일 ~ 5일
• 배송 안내 :

  
  

고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다

- 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
(단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
- 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
- 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
- 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
- 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
- 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
- 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.





해외원서의 경우
- 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
- 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
다시 한번 국내재고를 확인해 드립니다.

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

교환 및 반품정보

반품안내
전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.

반품가능기간
- 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)

- 주문하신 것과 다른 상품을 받으신 경우

- 파본인 상품을 받으신 경우
- 배송과정에서 손상된 상품을 받으신 경우

- 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)

- 탐독의 흔적이 있는 경우
- 소비자의 실수로 상품이 훼손된 경우
- 고객님의 주문으로 수입된 해외 도서인 경우
- 수령일로 14일 지난 상품의 경우

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
  이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

반품절차
- 배송완료후 3일 이내에 고객센터 02-854-2738 혹은 1:1 문의게시판을 통해 교환 및 반품 의사를 알려주세요.
- 도서는 택배 또는 등기우편으로 보내주시기 바랍니다.
- 14일 이내에 교환/반품/환불 받으실 상품이 회수되어야 하며, 반품과 환불의 경우 상품주문시 면제받으셨던
  배송비와 반품배송비까지 고객님께서 부담하시게 됩니다.

반품주소
(10881) 서울시 구로구 구로중앙로26길 32(구로동) 1층(성보의학서적)
전화) 02-854-2738

환불방법
- 대금은 반품 확인 후에, 카드취소/ 적립금 지급/ 계좌로 환불조치 해 드립니다.
- 카드결제 시 카드 승인취소절차를 밟게 되며 무통장입금시 현금 환불 혹은 적립금으로 변환 가능합니다.
- 반품도서와 함께 도서명, 주문번호와 환불계좌번호를 알려주시면 빠른 처리 가능합니다.

서비스문의

성보의학서적(Medical Book Store) 전화: 02) 854-2738 팩스: 02) 854-2808 이메일: medcore15@naver.com

고객센터: (02)854-2738